Rare Respiratory Diseases Research Group
ERR
GlaxoSmithKline (Spain)
Madrid, EspañaPublications in collaboration with researchers from GlaxoSmithKline (Spain) (5)
2020
-
Cost-effectiveness analysis of a once-daily single-inhaler triple therapy for patients with chronic obstructive pulmonary disease (COPD) using the fulfil trial: A Spanish perspective
International Journal of COPD, Vol. 15, pp. 1621-1632
-
Serum Levels of Alpha1-antitrypsin and Their Relationship With COPD in the General Spanish Population
Archivos de Bronconeumologia, Vol. 56, Núm. 2, pp. 76-83
2015
-
Does the COPD assessment test (CATTM) questionnaire produce similar results when self- or interviewer administered?
Quality of Life Research, Vol. 24, Núm. 10, pp. 2345-2354
-
Validation of a Spanish version of the childhood asthma control test (Sc-ACT) for use in Spain
Anales de Pediatria, Vol. 83, Núm. 2, pp. 94-103
2010
-
Geographical variations in the prevalence of COPD in Spain: Relationship to smoking, death rates and other determining factors
Archivos de Bronconeumologia, Vol. 46, Núm. 10, pp. 522-530